Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chlamydia screening in UK group's calls for workplace health drive:

This article was originally published in Clinica

Executive Summary

Chlamydia screening of men is one of a series of preventive health activities that could very effectively be conducted in the workplace, says UK pressure group Men's Health Forum (MHF), citing evidence that men are often reluctant to use traditional services. The idea was voiced ahead of this week's government summit on health, work and wellbeing and the launch of a charter on this theme. Well-targeted action and messages to men in the workplace can make a significant difference to their health, said the MHF, highlighting the success to date of initiatives to raise awareness of prostate disease, as well as chlamydia screening. "We know that if services are taken to men while they are at work, they are much more likely to use them," said MHF chief executive Peter Baker.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel